Detailled Information

Name of the Instrument/Tool Insomnia Severity Index (ISI)
First Description

Morin CM. Insomnia: psychological assessment and management. Treatment manuals for practitioners. New York: Guilford Press; 1993

Year 1991
Domains
Concept of constructs Sleep
Population/Disease Generic
Originally developed for ---
Other rheumatic diseases
where can be applied (only if validated)
Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), Osteoarthritis (OA), Fibromyalgia (FM)
Additional population with no rheumatic diseases Yes
PAtients with sleep disorders & cancer
Language: Originally published in English
Available in Language Arabic, German, Italian, French, Korean, Chinese, Spanish
REFERENCE IDENTIFICATION
Author/s Morin CM
Title Insomnia: psychological assessment and management. Treatment manuals for practitioners
Journal New York: Guilford Press
Year 1993
Vol ---
Num ---
Pages ---
Country Canada
Language English
Other references of interest
Link https://pubmed.ncbi.nlm.nih.gov/11438246/
Brief Description

Validation of the Insomnia Severity Index as an outcome measure for insomnia research.

Link https://pubmed.ncbi.nlm.nih.gov/22588751/
Brief Description

Interpreting score differences in the Insomnia Severity Index: using health-related outcomes to define the minimally important difference

Link https://pubmed.ncbi.nlm.nih.gov/33091275/Preliminary validat …
Brief Description

Measures of Sleep in Rheumatologic Diseases: Sleep Quality Patient‐Reported Outcomes in Rheumatologic Diseases

Instrument/Tool Translations References
Link https://pubmed.ncbi.nlm.nih.gov/29260018/
Brief Description

Reliability, factor analysis and internal consistency calculation of the Insomnia Severity Index (ISI) in French and in English among Lebanese adolescents

Link https://pubmed.ncbi.nlm.nih.gov/27234459/
Brief Description

 Validation study of the Italian version of the Insomnia Severity Index (ISI)

Link https://pubmed.ncbi.nlm.nih.gov/32124114/
Brief Description

Preliminary validation of the insomnia severity index in Danish outpatients with a medical condition

DEVELOPER CONTACT INFORMATION
Correspondence to Charles M. Morin
E-Mail cmorin@psy.ulaval.ca
Address 2325, rue des Bibliothèques, Québec, Canada
Website ---
Available ---
Links ---
DESCRIPTION OF THE INSTRUMENT
Type Of Measure Questionnaire
Brief Description

The ISI corresponds with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria for insomnia. The questions assess 1) sleep onset, 2) sleep maintenance, 3) early awakening, 4) satisfaction with sleep, 5) interference with daytime functioning, 6) noticeability of the sleep problem to others, and 7) distress caused by the sleep problem.

ISI measures insomnia symptoms and insomniarelated distress

Number of Items 7
Range 0-28
Responses options/scale Yes
Five-point Likert response, with a score of 0 corresponding to “not at all” or “very satisfied” and a score of 4 corresponding to “very much” or “very dissatisfied.”
Developed for Both
PRACTICAL APPLICATION
Method of administration Self-administered
Recommendations to score

The seven response items are summed to calculate a total score.

The authors suggest the following categories, defined by a range of scores: no clinically significant insomnia (range of 0-7), subthreshold insomnia (range of 8-14), moderate clinical insomnia (range of 15-21), and severe clinical insomnia (range of 22-28)

Score Interpretation ---
Cut-off points A cutoff score of 10 was optimal for detecting insomnia in a community-based sample (sensitivity: 86.1% & specificity: 87.7%) whereas a cutoff score of 11 was optimal for detecting insomnia in a clinical sample (sensitivity: 97.2% & specificity: 100%)
Cut-off points applied to Both
Smallest detectable change if described ---
Smallest detectable change applied to ---
Completion time by the patient <5 minutes
Scoring time by the assessor <1 minutes
Training to score Not necessary
Strengths Useful in clinical practice & research
Limitations ---
OTHER COMMENTS
Other Comments

The ISI is an excellent tool for assessing insomnia symptoms because its short length, feasibility, and applicability to both healthy and patient populations. For the diagnosis of insomnia, different optimal cutoffs have been determined in different populations and have yet to be validated against updated diagnostic criteria.